The effects of probiotic supplementation on metabolic status in type 2 diabetic patients with coronary heart disease
Assessed by RV022 · Health Service Researcher
Assessed on 29 Jun 2026
OverallReviewer's overall integrity assessment, derived from all research questions Serious concerns
DOI 10.1186/s13098-018-0353-2 (opens in new tab)
Resource ripekg:research-integrity-assessment/RIPEA084C6EAC9724305F
5 Research Questions · 52 Evidence Items
Q1.1 — Does the study have an associated retraction?
Rationale: No rationale provided
Supporting Evidence (1)
Retraction NoticeSource: Retraction Watch database
Effect of daily consumption of probiotic yoghurt on lipid profiles in pregnant women: a randomized controlled clinical trial
10.1080/14767058.2024.2364976 (opens in new tab)RetractionWatch ID:Record identifier in the Retraction Watch database 67044
Rationale: Concerns/Issues About Data;Concerns/Issues about Results and/or Conclusions;Investigation by Journal/Publisher;Investigation by Third Party;Objections by Author(s);Unreliable Results and/or Conclusions;Upgrade/Update of Prior Notice(s)
About Authors: Zatollah Asemi, Ahmad Esmaillzadeh
Q1.2 — Does the study have an associated expression of concern or other relevant post-publication notice?
Rationale: No rationale provided
Supporting Evidence (1)
PubPeer ThreadSource: PubPeer.com — post-publication peer review comments
https://pubpeer.com/publications/51526D446CE9F778E11D16A89CDA47 (opens in new tab)PubPeer CommentSource: PubPeer.com — a platform for post-publication peer review
There are many concerns about the integrity of 172 publications by this research group, including this one. Some of the concerns are published 1. Anaesthesia 2020;75:1683–92, see Supplementary data. This paper is A161 2. Account Res 2020;28:149-61. 3. J Clin Epidemiol 2021;131:22-29. Journals and publishers were notified of these concerns in July 2019. 18 publications have an expression of concern, and 6 have been retracted. To our knowledge there has been no public response about any of the concerns. We think these publications are unreliable
Thread: https://pubpeer.com/publications/51526D446CE9F778E11D16A89CDA47 (opens in new tab)
Q1.3 — Do other studies by the research team highlight causes for concern?
Rationale: No rationale provided
Supporting Evidence (48)
Retraction NoticeSource: Retraction Watch database
The effects of omega-3 fatty acids from flaxseed oil on genetic and metabolic profiles in patients with gestational diabetes mellitus: a randomized, double-blind, placebo-controlled trial
10.1017/s0007114521004037 (opens in new tab)RetractionWatch ID:Record identifier in the Retraction Watch database 43692
Rationale: Investigation by Journal/Publisher;Notice - Limited or No Information
About Authors: Mohsen Taghizadeh, Mehri Jamilian, Elaheh Amirani, Zohreh Tabassi, Mohammad Memarzadeh, Esmat Aghadavod, Mohammad Mansournia
Retraction NoticeSource: Retraction Watch database
The effects of synbiotic supplementation on markers of insulin metabolism and lipid profiles in gestational diabetes: a randomised, double-blind, placebo-controlled trial
10.1017/s0007114521002026 (opens in new tab)RetractionWatch ID:Record identifier in the Retraction Watch database 43694
Rationale: Investigation by Journal/Publisher;Notice - Limited or No Information
About Authors: Mehri Jamilian, Maryam Tajabadi-Ebrahimi
Retraction NoticeSource: Retraction Watch database
Calcium plus vitamin D supplementation influences biomarkers of inflammation and oxidative stress in overweight and vitamin D-deficient women with polycystic ovary syndrome: A randomized double-blind placebo-controlled clinical trial
10.1111/cen.14892 (opens in new tab)RetractionWatch ID:Record identifier in the Retraction Watch database 43979
Rationale: Investigation by Third Party
About Authors: Fatemeh Foroozanfard, Mehri Jamilian, Teibeh Hashemi, Ahmad Esmaillzadeh, Fereshteh Bahmani
Q2.2 — Are there concerns relating to the timing or absence of study registration?
Rationale: No rationale provided
Supporting Evidence (2)
Clinical Trial RegistrationSource: Clinical trial registry (e.g. ClinicalTrials.gov, ISRCTN)
Registration ID: IRCT2017082733941N5
Prospective:Whether the trial was registered before participant recruitment began No
Assessment Rationale:How INSPECT-AI determined the prospective registration status by comparing dates Registry registration date (study_first_submit_qc_date) is missing or empty.
Study Design EvidenceDates and timelines extracted by INSPECT-AI from the publication text
Recruitment Start: 10-2017
Recruitment Start Rationale:INSPECT-AI's reasoning for how it identified the recruitment start date Methods: 'from October 2017 through January 2018'. Used start of conducted range as recruitment_start per rule 5.
Recruitment End: N/A
Recruitment End Rationale:INSPECT-AI's reasoning for how it identified the recruitment end date No specific last patient in (LPI) date found; the range end is used for study_end_date per rule 5.
Study End: 01-2018
Study End Rationale:INSPECT-AI's reasoning for how it identified the study end date Methods: 'from October 2017 through January 2018'. Used end of conducted range as study_end_date per rule 5.
Overall — What is the overall integrity assessment of the study?
Rationale: No rationale provided